computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors.

Abstract in brief

• The study focuses on developing new JAK3 inhibitors, which are important for treating autoimmune diseases and cancer, by targeting a recently discovered protein structure (PDB ID 4Z16) that allows covalent bonding with a specific residue (Cys909).
• Researchers used Monte Carlo computational methods to predict and validate eleven potential molecules, narrowing down to six promising compounds based on their activity and drug-like properties, and then tested these using various techniques like molecular docking, molecular dynamics (MD) simulations, and free energy calculations.
• The results indicated that these new compounds could be effective JAK3 inhibitors, showing better performance than existing compounds, and offer promising insights for developing new treatments for autoimmune disorders and related diseases.